Skyline Venture Partners Qualified Purchaser Fund Iv L P - Net Worth and Insider Trading

Skyline Venture Partners Qualified Purchaser Fund Iv L P Net Worth

The estimated net worth of Skyline Venture Partners Qualified Purchaser Fund Iv L P is at least $701,365 dollars as of 2024-11-13. Skyline Venture Partners Qualified Purchaser Fund Iv L P is the 10% Owner of Concert Pharmaceuticals Inc and owns about 32,372 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $270,954. Skyline Venture Partners Qualified Purchaser Fund Iv L P is the 10% Owner of Tetraphase Pharmaceuticals Inc and owns about 109,507 shares of Tetraphase Pharmaceuticals Inc (TTPH) stock worth over $240,915. Skyline Venture Partners Qualified Purchaser Fund Iv L P is also the Director, 10% Owner of Talphera Inc and owns about 208,097 shares of Talphera Inc (TLPH) stock worth over $189,368. Besides these, Skyline Venture Partners Qualified Purchaser Fund Iv L P also holds ARCA biopharma Inc (ABIO) . Details can be seen in Skyline Venture Partners Qualified Purchaser Fund Iv L P's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Skyline Venture Partners Qualified Purchaser Fund Iv L P has not made any transactions after 2014-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Skyline Venture Partners Qualified Purchaser Fund Iv L P

To

Skyline Venture Partners Qualified Purchaser Fund Iv L P Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Skyline Venture Partners Qualified Purchaser Fund Iv L P owns 5 companies in total, including Protara Therapeutics Inc (TARA) , Tetraphase Pharmaceuticals Inc (TTPH) , and Talphera Inc (TLPH) among others .

Click here to see the complete history of Skyline Venture Partners Qualified Purchaser Fund Iv L P’s form 4 insider trades.

Insider Ownership Summary of Skyline Venture Partners Qualified Purchaser Fund Iv L P

Ticker Comapny Transaction Date Type of Owner
TARA Protara Therapeutics Inc 2014-10-21 10 percent owner
TTPH Tetraphase Pharmaceuticals Inc 2014-03-12 10 percent owner
TLPH Talphera Inc 2012-05-29 director & 10 percent owner
LIMIT LIMIT 2014-02-12 10 percent owner
LIMIT LIMIT 2009-01-27 10 percent owner

Skyline Venture Partners Qualified Purchaser Fund Iv L P Latest Holdings Summary

Skyline Venture Partners Qualified Purchaser Fund Iv L P currently owns a total of 4 stocks. Among these stocks, Skyline Venture Partners Qualified Purchaser Fund Iv L P owns 32,372 shares of Concert Pharmaceuticals Inc (CNCE) as of February 12, 2014, with a value of $270,954 and a weighting of 38.63%. Skyline Venture Partners Qualified Purchaser Fund Iv L P owns 109,507 shares of Tetraphase Pharmaceuticals Inc (TTPH) as of March 25, 2013, with a value of $240,915 and a weighting of 34.35%. Skyline Venture Partners Qualified Purchaser Fund Iv L P also owns 208,097 shares of Talphera Inc (TLPH) as of May 29, 2012, with a value of $189,368 and a weighting of 27%. The other 1 stocks ARCA biopharma Inc (ABIO) have a combined weighting of 0.02% among all his current holdings.

Latest Holdings of Skyline Venture Partners Qualified Purchaser Fund Iv L P

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNCE Concert Pharmaceuticals Inc 2014-02-12 32,372 8.37 270,954
TTPH Tetraphase Pharmaceuticals Inc 2013-03-25 109,507 2.20 240,915
TLPH Talphera Inc 2012-05-29 208,097 0.91 189,368
ABIO ARCA biopharma Inc 2009-01-27 5 25.50 128

Holding Weightings of Skyline Venture Partners Qualified Purchaser Fund Iv L P


Skyline Venture Partners Qualified Purchaser Fund Iv L P Form 4 Trading Tracker

According to the SEC Form 4 filings, Skyline Venture Partners Qualified Purchaser Fund Iv L P has made a total of 0 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 0 shares on February 12, 2014, which brought Skyline Venture Partners Qualified Purchaser Fund Iv L P around $0.

According to the SEC Form 4 filings, Skyline Venture Partners Qualified Purchaser Fund Iv L P has made a total of 0 transactions in Tetraphase Pharmaceuticals Inc (TTPH) over the past 5 years. The most-recent trade in Tetraphase Pharmaceuticals Inc is the acquisition of 34,051 shares on March 25, 2013, which cost Skyline Venture Partners Qualified Purchaser Fund Iv L P around $5 Million.

According to the SEC Form 4 filings, Skyline Venture Partners Qualified Purchaser Fund Iv L P has made a total of 0 transactions in Talphera Inc (TLPH) over the past 5 years. The most-recent trade in Talphera Inc is the acquisition of 14,235 shares on May 29, 2012, which cost Skyline Venture Partners Qualified Purchaser Fund Iv L P around $967,973.

More details on Skyline Venture Partners Qualified Purchaser Fund Iv L P's insider transactions can be found in the Insider Trading History of Skyline Venture Partners Qualified Purchaser Fund Iv L P table.

Insider Trading History of Skyline Venture Partners Qualified Purchaser Fund Iv L P

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Skyline Venture Partners Qualified Purchaser Fund Iv L P Trading Performance

GuruFocus tracks the stock performance after each of Skyline Venture Partners Qualified Purchaser Fund Iv L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Skyline Venture Partners Qualified Purchaser Fund Iv L P is -4.74%. GuruFocus also compares Skyline Venture Partners Qualified Purchaser Fund Iv L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Skyline Venture Partners Qualified Purchaser Fund Iv L P within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Skyline Venture Partners Qualified Purchaser Fund Iv L P's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Skyline Venture Partners Qualified Purchaser Fund Iv L P

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -5.18 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -4.67 LIMIT LIMIT LIMIT LIMIT LIMIT

Skyline Venture Partners Qualified Purchaser Fund Iv L P Ownership Network

Ownership Network List of Skyline Venture Partners Qualified Purchaser Fund Iv L P

No Data

Ownership Network Relation of Skyline Venture Partners Qualified Purchaser Fund Iv L P

Insider Network Chart

Skyline Venture Partners Qualified Purchaser Fund Iv L P Owned Company Details

What does Protara Therapeutics Inc do?

Who are the key executives at Protara Therapeutics Inc?

Skyline Venture Partners Qualified Purchaser Fund Iv L P is the 10 percent owner of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .

Protara Therapeutics Inc (TARA) Insider Trades Summary

Over the past 18 months, Skyline Venture Partners Qualified Purchaser Fund Iv L P made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 220,893 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 220,893 shares. During the past 18 months, 703,460 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 703,460 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Protara Therapeutics Inc Insider Transactions

No Available Data

Skyline Venture Partners Qualified Purchaser Fund Iv L P Mailing Address

Above is the net worth, insider trading, and ownership report for Skyline Venture Partners Qualified Purchaser Fund Iv L P. You might contact Skyline Venture Partners Qualified Purchaser Fund Iv L P via mailing address: 125 University Ave, Palo Alto Ca 94301.